TWi Biotechnology, Inc. (TPEX:6610)

Taiwan · Delayed Price · Currency is TWD

26.75

-0.75 (-2.73%)

Jun 18, 2026, 2:59 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development and Transfer of New Drug Technologies					66.40M	1.25M	9.66M	25.84M	74.97M
Development and Transfer of New Drug Technologies Growth					5228.81%	-87.11%	-62.60%	-65.54%	-
Total					66.40M	1.25M	9.66M	25.84M	74.97M
Total Growth					5228.81%	-87.11%	-62.60%	-65.54%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan					25.12M	-	-	-	-
China					41.28M	-	-	-	-
United States					-	1.25M	9.66M	25.84M	74.97M
United States Growth					-	-87.11%	-62.60%	-65.54%	-
Total					66.40M	1.25M	9.66M	25.84M	74.97M
Total Growth					5228.81%	-87.11%	-62.60%	-65.54%	-